相似文献
1
Specific amino acid substitutions cause distinct expression of JAL (RH48) and JAHK (RH53) antigens in RhCE and not in RhD.
Transfusion. 2010 Jan;50(1):267-9. doi: 10.1111/j.1537-2995.2009.02446.x.
2
Molecular basis of the JAHK (RH53) antigen.
Transfusion. 2005 Aug;45(8):1314-8. doi: 10.1111/j.1537-2995.2005.00200.x.
3
The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.
Transfusion. 2009 Apr;49(4):725-32. doi: 10.1111/j.1537-2995.2008.02034.x. Epub 2008 Dec 23.
4
Molecular basis of the Rh antigen RH48 (JAL).
Vox Sang. 2009 Apr;96(3):234-9. doi: 10.1111/j.1423-0410.2008.01142.x. Epub 2008 Dec 12.
5
Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities.
Transfus Clin Biol. 2021 Aug;28(3):314-320. doi: 10.1016/j.tracli.2021.04.007. Epub 2021 Apr 22.
6
The red cell antigen JAL in the Swiss population: family studies showing that JAL is an Rh antigen (RH48).
Vox Sang. 1990;59(1):44-7. doi: 10.1111/j.1423-0410.1990.tb02113.x.
7
JAHK: a low frequency antigen associated with the rG complex of the Rh blood group system.
Transfus Med. 2002 Feb;12(1):55-61. doi: 10.1046/j.1365-3148.2002.00348.x.
8
RhCE protein variants in Southwestern Germany detected by serologic routine testing.
Transfusion. 2009 Sep;49(9):1793-802. doi: 10.1111/j.1537-2995.2009.02220.x. Epub 2009 May 18.
9
Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors.
Blood Transfus. 2016 Sep;14(5):449-54. doi: 10.2450/2016.0275-15. Epub 2016 Apr 28.
10
JAL (RH48) blood group antigen: serologic observations.
Transfusion. 2009 Apr;49(4):719-24. doi: 10.1111/j.1537-2995.2008.02025.x. Epub 2008 Dec 15.
引用本文的文献
1
Molecular and computational analysis of 45 samples with a serologic weak D phenotype detected among 132,479 blood donors in northeast China.
J Transl Med. 2019 Nov 27;17(1):393. doi: 10.1186/s12967-019-02134-9.
2
It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
Transfusion. 2015 Mar;55(3):680-9. doi: 10.1111/trf.12941. Epub 2014 Dec 1.
3
Phasing-in RHD genotyping.
Arch Pathol Lab Med. 2014 May;138(5):585-8. doi: 10.5858/2013-0509-ED.
本文引用的文献
1
RhCE protein variants in Southwestern Germany detected by serologic routine testing.
Transfusion. 2009 Sep;49(9):1793-802. doi: 10.1111/j.1537-2995.2009.02220.x. Epub 2009 May 18.
2
Molecular basis of the Rh antigen RH48 (JAL).
Vox Sang. 2009 Apr;96(3):234-9. doi: 10.1111/j.1423-0410.2008.01142.x. Epub 2008 Dec 12.
3
The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.
Transfusion. 2009 Apr;49(4):725-32. doi: 10.1111/j.1537-2995.2008.02034.x. Epub 2008 Dec 23.
4
The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids.
Transfusion. 2006 May;46(5):766-72. doi: 10.1111/j.1537-2995.2006.00795.x.
5
Molecular basis of the JAHK (RH53) antigen.
Transfusion. 2005 Aug;45(8):1314-8. doi: 10.1111/j.1537-2995.2005.00200.x.
6
Weak D alleles express distinct phenotypes.
Blood. 2000 Apr 15;95(8):2699-708.
7
Molecular background of VS and weak C expression in blacks.
Transfusion. 1997 Jan;37(1):38-44. doi: 10.1046/j.1537-2995.1997.37197176949.x.
Zotero 插件